ERBB2 and carcinoma: Indeed, Schettini and collaborators [4] found higher levels of ERBB2 mRNA in H2L than in HER2-negative HR+ carcinomas, with higher levels in 2+ H2L carcinomas than in 1+ H2L carcinomas.